PACKAGE LEAFLET: INFORMATION FOR THE USER
Strefen 8.75 mg orange-flavored lozenges
Flurbiprofen
Read the package leaflet carefully before starting to take this medication, as it contains important information for you.
Follow the administration instructions for the medication contained in this package leaflet or as indicated by your doctor or pharmacist.
Contents of the package leaflet:
Strefen contains flurbiprofen. Flurbiprofen belongs to a group of medications called non-steroidal anti-inflammatory drugs (NSAIDs) that have analgesic, antipyretic, and anti-inflammatory properties. It is used for the relief of symptoms of sore throat such as irritation, pain, difficulty swallowing, and throat inflammation in adults and adolescents from 12 years of age.
You should consult a doctor if your symptoms worsen or do not improve after 3 days of treatment.
Do not take Strefen:
Warnings and precautions
Consult your doctor or pharmacist before starting to take Strefen:
if you are intolerant to some sugars
Infections
Non-steroidal anti-inflammatory drugs (NSAIDs) may mask signs of infection such as fever and pain. This may delay the start of appropriate treatment for the infection, which may lead to a greater risk of complications. If you take this medication while you have an infection and your symptoms persist or worsen, consult your doctor or pharmacist without delay.
While using Strefen
Children
This medication should not be used by children or adolescents under 12 years of age.
Taking Strefen with other medications
Inform your doctor or pharmacist if you are taking, have recently taken, or may need to take another medication. In particular, if you are taking:
Taking Strefen with food, drinks, and alcohol
Alcohol consumption should be avoided during treatment with Strefen, as it may increase the risk of stomach or intestinal bleeding.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Do not take this medicationif you are in the last trimester of pregnancy. If you are in the first 6 months of pregnancy or are breastfeeding, consult your doctor before taking this medication.
Flurbiprofen belongs to a group of medications that may affect fertility in women. This effect is reversible when the medication is stopped. It is unlikely that occasional use of this medication can affect your chances of becoming pregnant; however, inform your doctor before taking this medication if you have problems conceiving.
Driving and using machines
No studies have been conducted on the effects of the medication on the ability to drive or use machines. However, dizziness and visual disturbances are possible side effects after taking NSAIDs. If you are affected, do not drive or use machines.
Important information about some of the components of Strefen:
This medication contains isomalt (E953) and liquid maltitol (E965). If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication. It may have a mild laxative effect because it contains 2033.29 mg of isomalt (E953) and 509.31 mg of liquid maltitol (E965) per lozenge.
Caloric value: 2.3 kcal/g maltitol or isomalt.
This medication contains fragrances with citral, citronellol, d-limonene, geraniol, and linalool.
Citral, citronellol, d-limonene, geraniol, and linalool may cause allergic reactions.
Follow the administration instructions for the medication contained in this package leaflet or as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist.
The recommended doseis:
Adults and adolescents over 12 years of age:
1 lozenge every 3-6 hours, as needed.
Use in children:
Children under 12 years of age should not take this medication.
How to take:
These lozenges are for short-term treatment only.The lowest effective dose should be used for the shortest necessary duration to relieve symptoms. If you have an infection, consult a doctor or pharmacist without delay if symptoms (such as fever and pain) persist or worsen (see section 2). If irritation occurs in the mouth, treatment with the medication should be discontinued.
Do not take Strefen for more than 3 days, unless recommended by your doctor. If you do not improve, worsen, or if new symptoms appear, consult your doctor or pharmacist.
If you take more Strefen than you should
Call a doctor or go to the nearest hospital immediately. Symptoms of overdose may include: nausea or vomiting, stomach pain, or more rarely, diarrhea, ringing in the ears, headache, and gastrointestinal bleeding.
Call a doctor or go to the nearest hospital immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount taken.
If you have any other questions about the use of this product, ask your doctor or pharmacist.
If you forget to take Strefen
Do not take a double dose to make up for forgotten doses.
Like all medications, this medication can cause side effects, although not everyone will experience them.
STOP TAKING this medication and consult your doctor immediately if you notice:
Inform your doctor or pharmacist if you observe any of the following effects or any effect not described in this package leaflet:
Common(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Frequency not known(cannot be estimated from available data)
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a side effect not listed in this package leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use (www.notificaram.es). By reporting side effects, you can help provide more information on the safety of this medication.
If you experience side effects, consult your doctor or pharmacist, even if they are side effects not listed in this package leaflet.
Medications should not be disposed of through wastewater or household waste. Deposit the packaging and medications you no longer need at the SIGRE collection point in the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.
Composition of Strefen
The active ingredient (the component that makes the medication effective) is flurbiprofen 8.75 mg. The other components (excipients) are: macrogol 300, potassium hydroxide (E525), orange flavor, levomenthol, acesulfame potassium (E950), liquid maltitol (E965), and isomalt (E953).
Appearance of the product and package contents
The lozenges are round, white to light yellow in color with the brand logo embossed. The package contains 16 lozenges.
Marketing authorization holder and manufacturer:
Marketing authorization holder
RECKITT BENCKISER HEALTHCARE, S.A.
C/ Mataró, 28
08403 Granollers (Spain)
Manufacturer
RB NL Brands B.V.
Schiphol Blvd 207, 1118 BH Schiphol, Netherlands
This medication is authorized in the member states of the European Economic Area under the following names:
Germany | Dobendan Direkt Zuckerfrei Flurbiprofen 8,75 mg Lutschtabletten |
Austria | Strepsils Orange Zuckerfrei 8,75 mg Lutschtabletten |
Belgium | Strefen Suikervrij Sinaasappel 8.75mg zuigtabletten |
Cyprus | Strepfen Orange Sugar Free 8,75 mg Lozenge |
Denmark | Stefen Orange 8,75mg sukkerfri, Sugetabletter |
Slovenia | Strefen brez sladkorja z okusom pomarance 8,75mg pastile |
Spain | Strefen 8,75 mg pastillas para chupar sabor naranja |
Estonia | Strepsils Intensive Orange 8,75 g losengid (suhkruvaba) |
Finland | Strefen Orange 8,75mg Imeskelytabletti |
Greece | Strepfen Orange 8,75 mg Lozenge |
Iceland | Strefen Orange 8,75mg Sukkerfri, munnsogstöflur |
Lithuania | Strepsils Intensive Orange 8.75mg kietosias pastiles (be cukraus) |
Luxembourg | Strepfen Sans Sucre Orange 8.75mg pastilles |
Netherlands | Strepfen Sinaasappel 8,75 mg zuigtabletten |
Portugal | Strepfen Laranja sem açúcar 8,75 mg Pastilhas |
United Kingdom | Flurbiprofen 8.75mg lozenges |
Sweden | Strefen Apelsin 8,75mg sockerfri, sugtabletter |
Date of the last revision of this package leaflet:February 2024
Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS): http://www.aemps.gob.es/